PineStone Asset Management Inc. lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.5% in the fourth quarter, Holdings Channel reports. The firm owned 865,875 shares of the healthcare conglomerate’s stock after selling 13,287 shares during the period. UnitedHealth Group accounts for 4.1% of PineStone Asset Management Inc.’s investment portfolio, making the stock its 7th biggest position. PineStone Asset Management Inc.’s holdings in UnitedHealth Group were worth $438,012,000 as of its most recent filing with the SEC.
Other institutional investors also recently bought and sold shares of the company. AMF Tjanstepension AB boosted its position in UnitedHealth Group by 88.0% in the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock valued at $151,374,000 after buying an additional 121,180 shares during the last quarter. Hudson Value Partners LLC raised its holdings in shares of UnitedHealth Group by 8.3% during the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after purchasing an additional 82 shares during the period. Wealth Group Ltd. grew its position in shares of UnitedHealth Group by 4.0% during the 3rd quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock valued at $1,039,000 after buying an additional 68 shares during the last quarter. Creative Planning lifted its holdings in UnitedHealth Group by 11.0% in the third quarter. Creative Planning now owns 212,295 shares of the healthcare conglomerate’s stock worth $123,025,000 after acquiring an additional 21,114 shares during the last quarter. Finally, Good Life Advisors LLC lifted its holdings in shares of UnitedHealth Group by 50.6% in the 3rd quarter. Good Life Advisors LLC now owns 1,545 shares of the healthcare conglomerate’s stock worth $903,000 after purchasing an additional 519 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at UnitedHealth Group
In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.33% of the company’s stock.
Wall Street Analyst Weigh In
Check Out Our Latest Research Report on UnitedHealth Group
UnitedHealth Group Price Performance
NYSE UNH opened at $523.48 on Friday. The company has a 50 day moving average price of $523.63 and a two-hundred day moving average price of $563.48. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The stock has a market capitalization of $481.75 billion, a PE ratio of 33.77, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the business posted $5.83 earnings per share. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- How to Use Stock Screeners to Find Stocks
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Canada Bond Market Holiday: How to Invest and Trade
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- 3 Healthcare Dividend Stocks to Buy
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.